NCT01460368View on ClinicalTrials.gov

A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY2409021

Administered orally

DRUG

Placebo

Administered orally

DRUG

Moxifloxacin

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01460368 - A Study on the Effects of LY2409021 on the Electrical Impulses of the Heart | Biotech Hunter | Biotech Hunter